Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | X014729 | — |
so far has not experienced any side effects; patient was accidently administered an expired dose of PNEUMOVAX 23 on Apr 10, 2025; This spontaneous report was received from a licensed practical nurse (LPN) referring to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 10-Apr-2025, the patient was accidently administered an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) (lot #X014729, expiration date: 22-Nov-2024) 0.5 mL for prophylaxis (strength and route of administration were not reported) (Expired product administered). At the time of the call, the reporter stated the patent received expired dose within the past thirty minutes, and so far, the patient had not experienced any side effects (No adverse event). At the reporting time, the outcome of the events was unknown. No further information provided. No additional adverse event (AE) or product quality complaint (PQC) was reported. The action taken with Pneumococcal Vaccine, Polyvalent (23-valent) was reported as not applicable.
Comments: not reported